Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases.
Mathew P, Thall PF, Bucana CD, Oh WK, Morris MJ, Jones DM, Johnson MM, Wen S, Pagliaro LC, Tannir NM, Tu SM, Meluch AA, Smith L, Cohen L, Kim SJ, Troncoso P, Fidler IJ, Logothetis CJ.
Mathew P, et al.
Clin Cancer Res. 2007 Oct 1;13(19):5816-24. doi: 10.1158/1078-0432.CCR-07-1269.
Clin Cancer Res. 2007.
PMID: 17908974
Clinical Trial.